Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age
暂无分享,去创建一个
H. Teppler | E. Acosta | M. Rizk | S. Nachman | B. Graham | C. Worrell | A. Wiznia | L. Wenning | Lihong Du | Carrie Fry | Betsy Smith | B. Homony | Chantelle Bennetto-Hood